The earnings call depicted a largely positive outlook for Clover Health, marked by significant growth in membership, revenue, and adjusted EBITDA. The company effectively highlighted its successful initiatives and technological advancements with Clover Assistant. Financial metrics showed considerable improvement, and the positive CMS rate notice added to the optimistic future outlook. However, there were some challenges with elevated inpatient utilization and past operational issues with claims payable, but these were minor in comparison to the overall robust performance.

Company Guidance -

Q3 2025

During Clover Health's first quarter 2025 earnings call, the company provided robust guidance reflecting significant growth and operational efficiency. Key metrics highlighted included a 30% increase in Medicare Advantage (MA) membership, 33% revenue growth, and a remarkable 279% improvement in adjusted EBITDA year-over-year. Adjusted net income also surged by 322%. The company reconfirmed its full-year 2025 guidance, expecting MA membership to average between 103,000 and 107,000, with insurance revenue projected between $1.8 billion and $1.875 billion. They anticipate adjusted SG&A to be between $355 million and $365 million, with adjusted EBITDA and net income now forecasted between $50 million and $70 million each. Insurance Benefit Expense Ratio (BER) is expected to range from 87% to 88%. Clover Health is optimistic about continuing its momentum into the rest of the year, driven by strategic investments in technology, specifically the Clover Assistant, and growth in their Clover Home Care Services and Counterpart Health strategy.

Significant Growth in Medicare Advantage Membership

The company reported a 30% increase in Medicare Advantage membership year-over-year, which contributed to strong revenue growth.

Robust Revenue and Adjusted EBITDA Growth

Revenue grew by 33% year-over-year, and adjusted EBITDA increased by a substantial 279%, reflecting the company's operational momentum.

Clover Assistant's Positive Impact

The Clover Assistant technology has been instrumental in improving health outcomes, including earlier diagnoses of diseases like chronic kidney disease and diabetes, and reducing hospitalizations for congestive heart failure.

Improved Financial Metrics

Adjusted net income grew by 322% year-over-year, and adjusted SG&A as a percentage of total revenue decreased by 360 basis points.

Successful Stock Buyback Program

The company successfully repurchased 5 million shares, completing the remaining $80 million authorized under its buyback program.

Positive CMS Final Rate Notice for 2026

The recent CMS final rate notice is expected to add momentum, especially with the introduction of a 4 Star PPO plan.

Clover Health Investments (CLOV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CLOV Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.01 / -	-0.02	―	―	―
Aug 05, 2025	2025 (Q2)	>-0.01 / -0.02	0.01	-300.00% (-0.03)
May 06, 2025	2025 (Q1)	-0.04 / 0.05	-0.05	206.00% (+0.10)
Feb 27, 2025	2024 (Q4)	-0.07 / -0.04	-0.146	72.60% (+0.11)
Nov 06, 2024	2024 (Q3)	-0.04 / -0.02	-0.086	76.74% (+0.07)
Aug 05, 2024	2024 (Q2)	-0.05 / 0.01	-0.06	116.67% (+0.07)
May 07, 2024	2024 (Q1)	-0.07 / -0.05	-0.152	67.11% (+0.10)
Mar 12, 2024	2023 (Q4)	-0.14 / -0.15	-0.176	17.05% (+0.03)
Nov 06, 2023	2023 (Q3)	-0.11 / -0.09	-0.158	45.57% (+0.07)
Aug 08, 2023	2023 (Q2)	-0.14 / -0.06	-0.219	72.60% (+0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CLOV Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$2.85	―	―
May 06, 2025	$3.35	$3.77	+12.54%
Feb 27, 2025	$4.14	$3.97	-4.11%
Nov 06, 2024	$4.35	$3.67	-15.63%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.